Treatment Landscape of Macular Disorders in Indian Patients with the Advent of Razumab™ (World’s First Biosimilar Ranibizumab): A Comprehensive Review

Ranibizumab is approved for the treatment of several macular disorders, including wet age-related macular degeneration (wet AMD), diabetic macular edema (DME), retinal vein occlusion (RVO) and myopic choroidal neovascularization (mCNV), among others. The unaffordability of the innovator ranibizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Shashikant, Sharma, Tanishq, Prasad, Somdutt, Gopalakrishnan, Mahesh, Chaturvedi, Alok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216589/
https://www.ncbi.nlm.nih.gov/pubmed/34155608
http://dx.doi.org/10.1007/s40123-021-00362-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216589/
https://www.ncbi.nlm.nih.gov/pubmed/34155608
http://dx.doi.org/10.1007/s40123-021-00362-1

Ejemplares similares